DAY 1 | NEPHROLOGY & TRANSPLANTATION UPDATE COURSE – Saturday 8th September 2018 | |
GENERAL NEPHROLOGY: DIABETES & ITS COMPLICATIONS | Theme sponsored by AMGEN | ||
0800-0830 | Update in management of diabetic nephropathy Sydney Tang |
|
0830-0900 | Update in management of diabetic eye disease Paul Mitchell |
|
0900-0930 | Update in management of diabetic neuropathy Arun Krishnan (audio only) |
|
0930-1000 | Update in management of cardiovascular disease in diabetics Angela Wang |
|
GENERAL NEPHROLOGY: CHRONIC KIDNEY DISEASE | Theme sponsored by AMGEN | ||
1020-1050 | Blood pressure target in diabetic with CKD Vlado Perkovic |
|
1050-1120 | Update in treatment of membranous nephropathy Adrian Liew |
|
1120-1150 | Transition care: From paediatrics to adults – processes and procedures Matthew Jose (partial slide sharing) |
|
1150-1220 | Update in treatment options in adult dominant polycystic kidney disease Gopi Rangan |
|
|
||
TRANSPLANTATION: KIDNEY TRANSPLANT RECIPIENTS | Theme sponsored by NOVARTIS | ||
1310-1340 | Focal segmental glomerulosclerosis (FSGS): It is not just about proteinuria Minnie Sarwal (audio only) |
|
1340-1410 | Management of conception in kidney transplant recipient Shilpa Jesudason |
|
|
||
1410-1440 | Cancer screening post renal transplant – how far and how long? Germaine Wong |
PDF Presentation PPT Slides only |
1440-1510 | Update in vaccines in kidney transplantation Nicole Gilroy |
Permission not provided – sensitive content |
TRANSPLANTATION: POST KIDNEY TRANSPLANTATION | Theme sponsored by NOVARTIS | ||
1530-1600 | Cardiovascular disease assessment pre- and post kidney transplantation Helen Pilmore |
Permission not provided – sensitive content |
1600-1630 | Update in immunosuppressant management in non-acute kidney transplant Natasha Rogers |
|
1630-1700 | Cross matching, DSA and Eplet matching – how much should you know? Narelle Watson, Kate Wyburn |
|
|
DAY 2 | NEPHROLOGY & TRANSPLANTATION UPDATE COURSE – Sunday 9th September 2018 – Day 2 | |
DIALYSIS: END STAGE KIDNEY DISEASE | Theme sponsored by BAXTER | ||
0800-0830 | Updates in peritoneal dialysis Yeoung Jee Cho |
PDF Presentation PPT Slides only |
0830-0900 | Haemodialysis frequency and duration – which is more important? Meg Jardine |
Permission not provided – sensitive content |
0900-0930 | Access surveillance – how and when? Shannon Thomas |
PDF Presentation PPT Slides only |
0930-1000 | Does pore size matter? The evidence of middle molecules clearance Colin Hutchison |
Permission not provided – sensitive content |
DIALYSIS: GENETIC & CLINICAL NEPHROLOGY | Theme sponsored by BAXTER | ||
1020-1100 | Challenging clinical cases in glomerulopathy Anna Greka |
Permission not provided – sensitive content |
1100-1140 | Application of genetic testing in clinical nephrology Michel Tchan |
|
1140-1220 | Update in diagnosis and management of atypical hemolytic uremic syndrome David Kavanagh |
|
|
||
1220-1310 | Advanced Trainee Lunchtime Meeting | |
DIALYSIS: RESEARCH | Theme sponsored by BAXTER | ||
1310-1340 | Clinical trial in ANZ Carmel Hawley (audio only) |
|
1340-1410 | REDUCCTION – an implementation trial Sradha Kotwal |
PDF Presentation PPT Slides only |
GENERAL NEPHROLOGY | Theme sponsored by AMGEN | ||
1410-1440 | New oral anticoagulants (NOAC) and chronic kidney disease Carol Pollock |
|
|
||
1440-1510 | Update in immunotherapy and the kidneys Jenny Lee |
PDF Presentation PPT Slides only |
GENERAL NEPHROLOGY | Theme sponsored by AMGEN | ||
1530-1600 | Practical steps in advanced care planning Sarah Roxburgh |
|
1600-1630 | Update in psychiatric aspects of chronic kidney disease Kirsty Morris |
|
1630-1700 | Update in diagnosis and management of chronic allograft nephropathy Phil O’Connell |
|
|